UK Medical Cannabis White Paper 2025
Having legalised the use of cannabis as an unlicensed medical treatment in 2018, the UK was initially slow to facilitate patient access to treatment. This has changed in recent years, and there is now an active patient base of approximately 50,000 - 60,000 in the UK, with an estimated 80,000 individuals expected to receive treatment with medical cannabis throughout 2025. The UK is already the second-largest medical cannabis market in Europe, estimated to surpass €269 million in sales in 2025. Click 'FREE DOWNLOAD', complete the form and you'll see a link to download the white paper directly.
UK Medical Cannabis White Paper 2025
Having legalised the use of cannabis as an unlicensed medical treatment in 2018, the UK was initially slow to facilitate patient access to treatment. This has changed in recent years, and there is now an active patient base of approximately 50,000 - 60,000 in the UK, with an estimated 80,000 individuals expected to receive treatment with medical cannabis throughout 2025. The UK is already the second-largest medical cannabis market in Europe, estimated to surpass €269 million in sales in 2025. Click 'FREE DOWNLOAD', complete the form and you'll see a link to download the white paper directly.
PARTNERS
OVERVIEW
KEY FINDINGS
Data Packages
As Trusted By
Insights
on the global cannabis industry
International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.